OpenLobby.EU
Explore

ARKEMA

Multinational company manufacturing and selling chemical specialty products and advanced materials in the world - 9,5 € Bn turnover 2024 - 21 100 employees end of 2024

Lobbying Activity

Meeting with Florina-Andreea Pantazi (Head of Unit Internal Market, Industry, Entrepreneurship and SMEs)

12 Jan 2026 · REACH Revision and Universal PFAS restriction under REACH

Meeting with Raphaël Glucksmann (Member of the European Parliament)

5 Jan 2026 · US tariffs

Meeting with Martin Hojsík (Member of the European Parliament, Shadow rapporteur)

28 Nov 2025 · Chemicals, PFAS, REACH, CLP

Meeting with Alexandra Hild (Cabinet of Commissioner Ekaterina Zaharieva)

16 Oct 2025 · Advanced Materials Act

Meeting with Paul Speight (Head of Unit Environment)

30 Sept 2025 · Reach Revision; PFAS restriction

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

16 Sept 2025 · REACH

Response to Technical updates of the Emissions Trading Scheme (ETS) State aid guidelines

5 Sept 2025

Arkema's position on technical updates to ETS State aid guidelines As a specialty chemicals and advanced materials leader in Europe, we support this revision in view of including additional chemical sectors, as announced in the European Chemicals Industry Action Plan communication of July 8. This will be essential to preserve the competitiveness of Europes energy-intensive industries while supporting their energy transition. Please find attached our position paper.
Read full response

Meeting with Miguel Jose Garcia Jones (Cabinet of Commissioner Wopke Hoekstra)

24 Jul 2025 · Discussion on the Chemicals Action Plan and the increase of an fgas black market

Meeting with Charlotte Merlier (Cabinet of Commissioner Maroš Šefčovič)

24 Jul 2025 · Trade and industrial policy

Meeting with Vita Jukne (Cabinet of Commissioner Jessika Roswall)

9 Jul 2025 · Chemical action plan and Chemical Industry Package

Response to EU emissions trading system for maritime, aviation and stationary installations, and market stability reserve - review

8 Jul 2025

Arkema recognises the need of a strong carbon price architecture and supports the objective of the ETS directive to unlock decarbonisation investments in a cost-effective manner. We welcome positively the simplification ambition of the European Commission and stress the need to have a flexible and pragmatic climate policy, considering the current technological, economic and geopolitical reality. Furthermore, we strongly support the view that the key to accelerate decarbonisation investments is to unlock critical public support and enable the competitiveness of the European industry, as was brought forward by the Clean Industrial Deal. We share with the Commission our proposal to balance decarbonisation with competitiveness and administratively simplify and improve the EU ETS.
Read full response

Meeting with Stéphane Séjourné (Executive Vice-President) and

27 Jun 2025 · Compétitivité; relations USE-UE, CSRD/CS3D, Simplification , chimie

Meeting with Arthur Corbin (Cabinet of Executive Vice-President Stéphane Séjourné), Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

20 May 2025 · REACH, Chemical Action Plan

Response to Drinking water - Establishing the procedure for amending the European Positive Lists ('EUPLs')

13 Nov 2023

Arkema welcomes the opportunity to provide written comments to the public consultation regarding the implementation of Article 11 of the Drinking Water Directive (DWD). As a manufacturer and a supplier of substances that can be used in the production of materials coming into contact with drinking water, Arkema will focus its comments on starting substances. We support the overall objectives of DWD. However we would like to express our deep concerns about the proposal, especially regarding inclusion in or removal from the European positive lists. The procedure, as described in the delegated act, will create legal uncertainty for the Dossier submitters that could lost all the benefits of their investments Indeed the constitution of a dossier in initial submissions requires significant investments:both in resources and costs of studies or purchase of letters of access to REACH studies. According to our understanding, the text under discussion could allow any other supplier to use the positive list to put its substance on the European market based on the dossier already submitted by the first submitter without any investements. This is clearly not in favour of innovation. We call the European commission for ensuring that applicants' investments and CBI are fully protected, therefore amending the delegated acts to this effect. The rules and practices implemented for Reach and Biocide regulation must be used as reference (consortia, letter of access, opt-out, joint submission). We strongly require the EU commission to ensure that a positive list is only valid for a referred group of dossiers submitters with established cost-sharing rules. A positive list should not be valid for legal entities that are not members of this group of applicants for one substance/dossier.
Read full response

Meeting with Thierry Breton (Commissioner) and

26 Jun 2023 · Overview of chemicals industry situation, transition pathway for chemicals industry, REACH revision

Meeting with Joost Korte (Director-General Employment, Social Affairs and Inclusion) and Vereniging VNO-NCW and

24 May 2023 · EU social policy making, European Pillar of Social Rights and future initiatives

Meeting with Filomena Chirico (Cabinet of Vice-President Jyrki Katainen) and Burson Cohn Wolfe SRL

15 Nov 2018 · Deteriorating market conditions for automotive air conditioning

Meeting with Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

21 Mar 2018 · refrigerant1234yf

Meeting with Agnieszka Drzewoska (Cabinet of Commissioner Elżbieta Bieńkowska), Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

18 Sept 2015 · Presentation of company's views on market evolution